The effects of intensive speech treatment on intelligibility in Spanish dysarthria secondary to Parkinson’s disease
Objective: To examine the effects of intensive speech treatment (LSVT-LOUD; Ramig et al., 2001) on intelligibility at conversational level in Spanish dysarthria secondary to Parkinson's…STEADY-PD III. A phase 3 study of isradipine as a disease modifying agent in patients with early Parkinson’s disease. Baseline characteristics of the enrolled cohort
Objective: To evaluate the efficacy of isradipine 10 mg daily on PD disability. Background: Isradipine, a dihydropyridine calcium channel antagonist with excellent penetration of the…A crossover study of pretarsal and preseptal injections of botulinum toxin type A (BTX-A) in the treatment of hemifacial spasm and blepharospasm
Objective: To compare the efficacy, patient satisfaction, and side effects between pretarsal and preseptal injection sites on BTX-A treatment in abnormal orbicularis oculi contraction in…Effect of outside influences on the therapeutic benefits of botulinum toxin injections
Objective: The purpose of this project is to determine if outside influences or stressors have an effect on the therapeutic benefit of botulinum toxin injections…Copper chelation efficacy of alginate/chitosan based D-penicillamine nanoparticles in rat model of non-Wilsonian brain copper toxicosis
Objective: To evaluate the copper (Cu) chelation efficacy of orally administered D-penicillamine loaded nanoparticles to that of conventional D-penicillamine therapy for 90 days in Wistar…Classification and recommendation of nonpharmacological therapies for Parkinson’s disease
Objective: A multidisciplinary specialized treatment including physiotherapy, speech and language therapy, occupational therapy (OT) associated to the ideal pharmacological treatment and surgical is recommended to…Multi-modal recruitment strategy leads to expeditious enrollment in STEADY-PD III
Objective: To review a successful multi-modal recruitment strategy in a clinical trial of early untreated PD patients. Background: STEADY-PD III is a multicenter NINDS funded…Transcranial versus root repeated magnetic stimulation as a treatment of psychogenic movement disorders
Objective: To determine whether the beneficial effect of repeated transcranial magnetic stimulation (rTMS) in psychogenic movement disorders (PMDs) is the consequence of a cortical functioning…Global implementation of efficacious voice treatment for Parkinson’s disease: LSVT LOUD: Germany®
Objective: This project was designed to evaluate the implementation of an efficacious voice treatment (LSVT LOUD) developed in the USA and designed to improve speech…Effect of right DLPFC-repetitive transcranial magnetic stimulation (rTMS) on tardive dyskinesia in patients with psychosis
Objective: The index study was done to examine any change in tardive dyskinesia, cognitive function and psychopathology following high frequency rTMS of the right Dorsolateral…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.